newsfilter
← Latest News
Business Wire·

Industry Veteran and VC Investor Strengthen the BTB Therapeutics Board

BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R. Snyder, Esq. and Nobuhiro Yagi, PhD to its board of